54 completed. 54 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 54 | Completed 54 |
| Phase 2 | 4 | Completed 4 |
Follow Allergic Rhinitis: new trials by email Literature Review of Allergic Rhinitis trials Research Report on Allergic Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 HDM SLIT-tablet (12 SQ-HDM), Placebo - Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 327 | 2025-09-01 | 2026-10-05 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 70 | 2024-11-11 | 2026-07-23 |
| Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children Desloratadine , Prednisolone, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 262 | 2024-07-08 | 2026-10-26 |
| Study of CM310 in Subjects With Allergic Rhinitis CM310, Placebo - Allergic Rhinitis | Phase 3 | Completed | Keymed Biosciences Co.Ltd | 108 | 2023-08-10 | 2024-11-08 |
| Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis REGN5713, REGN5714, REGN5715 - Allergic Rhinitis, Conjunctivitis | Phase 3 | Completed | Regeneron Pharmaceuticals | 353 | 2021-01-14 | 2022-10-27 |
| Adolescent Mite Allergy Safety Evaluation HDM SLIT-tablet - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Completed | ALK-Abelló A/S | 253 | 2020-09-23 | 2023-07-03 |
| Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis Azelastine hydrochloride (BAYR9258), Placebo - Allergic Rhinitis | Phase 3 | Completed | Bayer | 110 | 2020-02-03 | 2022-03-25 |
| "Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients" Phlai, Placebo oral capsule - Allergic Rhinitis | Phase 3 | Completed | Chulalongkorn University | 267 | 2020-01-31 | 2022-01-28 |
| Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray Rhinocort, Budesolv, Placebo - Allergic Rhinitis, Allergic Conjunctivitis | Phase 3 | Completed | Marinomed Biotech AG | 82 | 2018-11-19 | 2020-10-12 |
| The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis Radiofrequency turbinate reduction, Pharmacology treatment - Allergic Rhinitis | Phase 3 | Completed | Universitas Indonesia | 32 | 2018-07-01 | 2022-03-31 |
| DYmista NAsal Spray in CHInese Patients Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT, Azelastine Hydrochloride 0.137 MG/ACTUAT, Fluticasone Propionate 0.05 MG/ACTUAT - Allergic Rhinitis | Phase 3 | Completed | MEDA Pharma GmbH & Co. KG | 900 | 2018-06-29 | 2022-02-22 |
| Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis Ismigen, Placebo - Allergic Rhinitis | Phase 3 | Completed | Medical University of Lublin | 76 | 2018-04-22 | 2021-03-17 |
| Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus Ismigen, Placebo - Allergic Rhinitis | Phase 3 | Completed | Medical University of Lublin | 70 | 2018-04-22 | 2022-04-11 |
| Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua AIT drops, placebo drops - Allergic Rhinitis | Phase 3 | Completed | Beijing Tongren Hospital | 702 | 2017-03-20 | 2020-07-16 |
| Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis Purethal Birch immunotherapy, Placebo and symptomatic treatment - Allergic Rhinitis, Allergic Reaction | Phase 3 | Completed | Medical University of Silesia | 78 | 2014-01-05 | 2017-05-17 |
| Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean AGR tablet, Placebo (for AGR tablet and/or Active Comparator), Active Comparator - Allergic Rhinitis, Perennial Allergic Rhinitis | Phase 3 | Completed | Ahn-Gook Pharmaceuticals Co.,Ltd | 324 | 2013-12-01 | 2018-03-13 |
| Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment Dexchlorpheniramine + Betamethasone, Desloratadine + Prednisolone - Allergic Rhinitis | Phase 3 | Completed | EMS | 210 | 2013-11-01 | 2015-01-15 |
| Cellulose Powder Against Grass Pollen Allergic Rhinitis Nasaleze, Placebo - Allergic Rhinitis | Phase 2 / Phase 3 | Completed | Nasaleze International Ltd | 108 | 2013-05-01 | 2017-02-01 |
| 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis Dymista Nasal Spray, Fluticasone propionate nasal spray - Allergic Rhinitis | Phase 3 | Completed | Meda Pharmaceuticals | 405 | 2013-02-01 | 2015-03-31 |
| Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR) BDP Nasal Aerosol, Placebo - Allergic Rhinitis | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 547 | 2013-01-01 | 2015-10-12 |
Showing 20 of 54. Sign in to see all of them.
Rhinitis, Allergic (54) · Rhinitis, Allergic, Seasonal (11) · Hypersensitivity (10) · Rhinitis, Allergic, Perennial (6) · Asthma (4) · Rhinitis (3) · Chronic Urticaria (2) · Conjunctivitis, Allergic (2) · Bronchiolitis (1) · Conjunctivitis (1) · Constipation (1) · Croup (1) · Dermatitis, Atopic (1) · Nasal Obstruction (1) · Otitis Media (1)
Hypersensitivity, Immediate (54) · Immune System Diseases (54) · Nose Diseases (54) · Otorhinolaryngologic Diseases (54) · Respiratory Hypersensitivity (54) · Respiratory Tract Diseases (54) · Rhinitis (51) · Hypersensitivity (44) · Bronchial Diseases (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Infections (4) · Respiratory Tract Infections (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4)
desloratadine (7) · Mometasone Furoate (4) · levocetirizine (4) · Beclomethasone (3) · ciclesonide (3) · Betamethasone (2) · Broncho-Vaxom (2) · Cetirizine (2) · Fluticasone (2) · Prednisolone (2) · azelastine (2) · Abortion, Induced (1) · Budesonide (1) · Grazax (1) · Injections, Subcutaneous (1)
Organon and Co (9) · ALK-Abelló A/S (5) · AstraZeneca (3) · Chang Gung Memorial Hospital (2) · Eurofarma Laboratorios S.A. (2) · GlaxoSmithKline (2) · Medical University of Lublin (2) · Stallergenes Greer (2) · Teva Branded Pharmaceutical Products R&D, Inc. (2) · UCB Pharma (2) · Ahn-Gook Pharmaceuticals Co.,Ltd (1) · Bayer (1) · Beijing Tongren Hospital (1) · Chulalongkorn University (1) · Clinical Research International Limited (1)
United States (14) · China (6) · Germany (6) · Canada (3) · Poland (3) · Sweden (3) · Brazil (2) · Czechia (2) · Denmark (2) · Finland (2) · Italy (2) · Slovakia (2) · Taiwan (2) · Austria (1) · Belgium (1)
Andreas Fisher (1) · Andreas Horn, MD (1) · Chae-Seo Rhee, M.D. (1) · Chang-Hoon Kim, M.D. (1) · Chia-yu Ou, MD (1) · Dae-Woo Kim, M.D. (1) · DucTung Nguyen, Dr. (1) · Erkka Valovirta, MD (1) · Eva E Prieschl-Grassauer, PhD (1)
PMID 20819318, PMID 21439168, PMID 20559006, PMID 21121983, PMID 21888757, PMID 22131999, PMID 22370530, PMID 22925325, PMID 22994348, PMID 23676577, PMID 24388010, PMID 24517417, PMID 24852424, PMID 25624132, PMID 26115578, PMID 26250771, PMID 29273130, PMID 29490769, PMID 32858239, PMID 34965026, PMID 37580498, PMID 38356731, PMID 39035788, PMID 39067509, PMID 40051426, PMID 40186079
2009 (1), 2015 (1), 2018 (1), 2025 (1)